Quantcast
Last updated on April 23, 2014 at 10:33 EDT

Latest Lazard Stories

2013-11-20 12:23:16

NEW YORK, November 20, 2013 /PRNewswire/ -- PA Consulting Group today announced the appointment of Marcus Agius as Non-Executive Chairman as of January 1 2014. The appointment comes after the earlier announcement that Jon Moynihan, currently Executive Chairman of PA, would be retiring at the end of the year. Simultaneously, the Board had commenced a series of changes to refresh its membership, other long-serving members having expressed their wish to retire along with...

2013-11-13 08:28:51

Glenview Commends New HMA Board and Management for its Comprehensive Efforts to Stabilize the HMA Business NEW YORK, Nov. 13, 2013 /PRNewswire/ -- Glenview Capital Management LLC, which owns 14.5% of the common stock of Health Management Associates, Inc. (NYSE: HMA) through affiliated investment funds, today issued the following statement: "In light of our leadership role to Revitalize HMA and given our stance as HMA's largest shareholder, Glenview offers the following statement regarding...

2013-11-06 12:32:37

Firm Hires David Trone Director of Research/Banks Analyst and Ian Ing to Cover Semiconductors STAMFORD, Conn., Nov. 6, 2013 /PRNewswire/ -- MKM Partners today announced that David Trone has joined as Managing Director, Director of Research and Research Analyst covering banks and brokers. In addition, as a member of MKM's Equity Operating Committee, David will help grow the firm's institutional research, sales and trading platform. David joins MKM Partners most recently from JMP...

2013-08-08 12:21:54

MELBOURNE, Victoria, Aug. 8, 2013 /CNW/ - Newcrest Mining Limited (Newcrest) is pleased to announce the appointment of Peter Hay as a Non-Executive Director. His appointment is effective from today, 8 August 2013. Mr Hay brings to the Newcrest Board his strong background and breadth of experience in business, corporate law, finance and investment banking. Mr Hay is Chairman of the Advisory Board of Lazard & Co. Pty Ltd and has been a Director of Australia and New Zealand...

2013-07-23 08:30:40

LA JOLLA, Calif., July 23, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the completion of an underwritten public offering of 5,175,000 shares of common stock, including 675,000 shares sold pursuant to the full exercise of an option to purchase additional shares previously granted to the underwriters, at a price to the public of $9.50 per...

2013-07-17 08:26:03

LA JOLLA, Calif., July 17, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the pricing of a public offering of 4,500,000 shares of its common stock at a price of $9.50 per share. The gross proceeds to Regulus from this offering are expected to be approximately $42.8 million, before deducting underwriting discounts and commissions and estimated...

2013-07-11 20:21:04

KANSAS CITY, Kan. and BOSTON, July 11, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets, today announced the full exercise of the over-allotment option granted to the underwriters to purchase 862,500 additional shares of common stock, at a public offering price of $6.00 per share, in connection with its previously...

2013-06-27 08:29:18

KANSAS CITY, Kan. and BOSTON, June 27, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc., a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for pets, announced today the pricing of its initial public offering of 5,750,000 shares of its common stock at a price of $6.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on June 27, 2013 under the ticker symbol...

2013-06-27 08:23:38

TAMPA, Fla., June 27, 2013 /PRNewswire/ -- Seven Seas Water announced today the appointment of Mr. Brian O'Neill to its Board of Directors and affirmed its commitment to become a leader in Latin American desalination. (Logo: http://photos.prnewswire.com/prnh/20130627/FL38812LOGO ) Mr. O'Neill is a Senior Advisor at Lazard, a global financial advisory and asset management firm. He joined the firm in 2009 as Vice Chairman for Lazard International. Prior to Lazard, he was the Deputy...

2013-06-11 12:34:43

SAN JOSE, Calif., June 11, 2013 /PRNewswire/ -- Dr. Radoslav Danilak, CEO and co-founder of Skyera Inc., will speak on next-generation flash memory technologies at Solid State Storage Day, hosted by investment banking firm Lazard Capital Markets June 12 at the Grand Hyatt Hotel in New York. (Photo: http://photos.prnewswire.com/prnh/20120619/LA26849LOGO) The event aims to inform professionals and the firm's top clients on the future of flash in storage vis-a-vis enterprise...